Aemro Kassa

778 total citations
10 papers, 598 citations indexed

About

Aemro Kassa is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Aemro Kassa has authored 10 papers receiving a total of 598 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Virology, 4 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in Aemro Kassa's work include HIV Research and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Aemro Kassa is often cited by papers focused on HIV Research and Treatment (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and HIV/AIDS drug development and treatment (4 papers). Aemro Kassa collaborates with scholars based in United States, Netherlands and South Korea. Aemro Kassa's co-authors include Joseph Sodroski, Joel R. Courter, Amos B. Smith, Marie Pancera, Andrés Finzi, Beatriz Pacheco, Liping Wang, Navid Madani, Hillel Haim and Amy M. Princiotto and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Cell and PLoS ONE.

In The Last Decade

Aemro Kassa

10 papers receiving 596 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aemro Kassa United States 9 509 325 216 147 141 10 598
Nthabeleng Ranchobe South Africa 6 629 1.2× 285 0.9× 329 1.5× 175 1.2× 132 0.9× 6 684
Nancy Tumba South Africa 7 757 1.5× 297 0.9× 434 2.0× 253 1.7× 184 1.3× 10 890
Karen L. Saye-Francisco United States 9 476 0.9× 167 0.5× 266 1.2× 273 1.9× 273 1.9× 10 670
Maphuti Madiga South Africa 6 489 1.0× 204 0.6× 295 1.4× 140 1.0× 116 0.8× 9 569
Norbert Schuelke United States 4 687 1.3× 287 0.9× 293 1.4× 309 2.1× 262 1.9× 5 818
S Conley United States 8 463 0.9× 244 0.8× 199 0.9× 120 0.8× 54 0.4× 9 553
Ronald L. Willey United States 10 806 1.6× 358 1.1× 422 2.0× 184 1.3× 100 0.7× 12 884
Michael Humbert United States 11 355 0.7× 203 0.6× 161 0.7× 252 1.7× 186 1.3× 17 582
Molati Nonyane South Africa 5 368 0.7× 141 0.4× 192 0.9× 128 0.9× 95 0.7× 8 416
R S Liou United States 6 576 1.1× 312 1.0× 225 1.0× 196 1.3× 145 1.0× 8 673

Countries citing papers authored by Aemro Kassa

Since Specialization
Citations

This map shows the geographic impact of Aemro Kassa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aemro Kassa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aemro Kassa more than expected).

Fields of papers citing papers by Aemro Kassa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aemro Kassa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aemro Kassa. The network helps show where Aemro Kassa may publish in the future.

Co-authorship network of co-authors of Aemro Kassa

This figure shows the co-authorship network connecting the top 25 collaborators of Aemro Kassa. A scholar is included among the top collaborators of Aemro Kassa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aemro Kassa. Aemro Kassa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Criado, Miriã F., Aemro Kassa, Kateri Bertran, et al.. (2023). Efficacy of multivalent recombinant herpesvirus of turkey vaccines against high pathogenicity avian influenza, infectious bursal disease, and Newcastle disease viruses. Vaccine. 41(18). 2893–2904. 11 indexed citations
3.
Kassa, Aemro, Antu Dey, Celia C. LaBranche, et al.. (2013). Stabilizing Exposure of Conserved Epitopes by Structure Guided Insertion of Disulfide Bond in HIV-1 Envelope Glycoprotein. PLoS ONE. 8(10). e76139–e76139. 17 indexed citations
4.
Haim, Hillel, Bettina Strack, Aemro Kassa, et al.. (2011). Contribution of Intrinsic Reactivity of the HIV-1 Envelope Glycoproteins to CD4-Independent Infection and Global Inhibitor Sensitivity. PLoS Pathogens. 7(6). e1002101–e1002101. 101 indexed citations
5.
Schellinger, Joan G., et al.. (2011). Synthesis of a Trimeric gp120 Epitope Mimic Conjugated to a T-Helper Peptide To Improve Antigenicity. Journal of the American Chemical Society. 133(10). 3230–3233. 21 indexed citations
6.
Finzi, Andrés, Shi-Hua Xiang, Beatriz Pacheco, et al.. (2010). Topological Layers in the HIV-1 gp120 Inner Domain Regulate gp41 Interaction and CD4-Triggered Conformational Transitions. Molecular Cell. 37(5). 656–667. 161 indexed citations
7.
Haim, Hillel, Zhihai Si, Navid Madani, et al.. (2009). Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State. PLoS Pathogens. 5(4). e1000360–e1000360. 139 indexed citations
8.
Kassa, Aemro, Andrés Finzi, Marie Pancera, et al.. (2009). Identification of a Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Variant Resistant to Cold Inactivation. Journal of Virology. 83(9). 4476–4488. 43 indexed citations
9.
Kassa, Aemro, Navid Madani, Arne Schön, et al.. (2009). Transitions to and from the CD4-Bound Conformation Are Modulated by a Single-Residue Change in the Human Immunodeficiency Virus Type 1 gp120 Inner Domain. Journal of Virology. 83(17). 8364–8378. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026